Intratumoral Nanofluidic System for Enhancing Tumor Biodistribution of Agonist CD40 Antibody-Reference-Cited by-同舟云学术

Intratumoral Nanofluidic System for Enhancing Tumor Biodistribution of Agonist CD40 Antibody

Published:2020-07-09 Issue:10 Volume:3 Page:2000055
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Chua Corrine Ying Xuan¹,Ho Jeremy¹²,Susnjar Antonia¹,Lolli Graziano¹³,Di Trani Nicola¹⁴,Pesaresi Federica¹⁵,Zhang Mengying⁶,Nance Elizabeth⁶,Grattoni Alessandro¹⁷⁸^ORCID

Affiliation:

1. Department of Nanomedicine Houston Methodist Research Institute Houston TX 77030 USA

2. Weill Cornell Medical College New York NY 10065 USA

3. Department of Mechanical and Aerospace Engineering Polytechnic of Turin Turin 10129 Italy

4. University of Chinese Academy of Science (UCAS) Shijingshan, 19 Yuquan Road Beijing 100049 China

5. Department of Electronics and Telecommunications Polytechnic of Turin Turin 10129 Italy

6. Department of Chemical Engineering University of Washington Seattle WA 98195 USA

7. Department of Surgery Houston Methodist Hospital Houston TX 77030 USA

8. Department of Radiation Oncology Houston Methodist Hospital Houston TX 77030 USA

Funder

Golfers Against Cancer

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000055

Reference90 articles.

1. Drug penetration in solid tumours

2. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

3. Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle

4. Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

5. Association of Time-Varying Clearance of Nivolumab With Disease Dynamics and Its Implications on Exposure Response Analysis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy;Bioactive Materials;2024-11

2. An Insight into Perfusion Anisotropy within Solid Murine Lung Cancer Tumors;Pharmaceutics;2024-07-30

3. Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents;Gels;2024-01-05

4. Intratumoral nanofluidic system enhanced tumor biodistribution of PD‐L1 antibody in triple‐negative breast cancer;Bioengineering & Translational Medicine;2023-09-15

5. Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer;Advanced Science;2023-01-19